Navigation Links
Cancer Patients are at High Risk for Potential Drug Interactions

Potential drug interactions from prescribed medications are common among cancer patients and may cause// unnecessary harm, according to a study in the April 18 Journal of the National Cancer Institute.

Cancer patients often take several medications at the same time, not only for treating their cancer but also for side effects and other secondary illnesses. Because of this, they can be at high risk for adverse drug interactions and duplicate medications. Consequences of these interactions can range from inactivation of cancer-fighting medications to severely injuring or killing the patient.

Rachel Riechelmann, M.D., of the Princess Margaret Hospital in Toronto, and colleagues gave 405 cancer patients a questionnaire about the medications they had taken in the last four weeks. Their responses were analyzed using a drug interaction software program that could identify potential interactions and rank them by severity.

Nearly a third of patients were exposed to at least one potential drug interaction. The researchers identified 276 drug combinations with the potential to interact. About nine percent of the interactions considered of major severity—risk of death—and 77 percent of moderate severity—risk of serious health problems. About eight percent of the patients received duplicate medications.

The researchers found that some of the drugs interacted with anticancer medications. The most common were warfarin (a drug to prevent blood clots), antihypertension drugs, aspirin and anticonvulsants. Warfarin stood out because it can cause hemorrhages when used with certain chemotherapy medications, and the interaction can interfere with its metabolism. Additionally, patients with brain tumors were at particularly high risk since they are often prescribed anticonvulsants.

"We suggest that patients at high risk… be routinely screened for potential drug interactions. The development of medication databases and computerize
'"/>




Page: 1 2

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cancer Patients are High Risk for Potential Drug Interactions

(Date:5/22/2013)... 22, 2013 In partnership with ... Surge, LLC, E-Dentists.com has launched a new SEO ... feature numerous topics of interest to dentists and ... dental health. , http://www.E-Dentists.com/Blog/ , Blogging ... marketing. In addition to addressing keyword placement and ...
(Date:5/22/2013)... May 22, 2013 Teams who focus ... improvements use the new Do-Done StepTracker whiteboard as a ... the Do-Done board to display the current status of ... production cells and departments is listed down the side ... start a project, the squares are filled with yellow ...
(Date:5/22/2013)... MA New research from Brigham and Women,s Hospital ... fibrosis, an uncommon but deadly lung disease, may be ... These findings will be presented at the American ... the New England Journal of Medicine on ... 2013 print edition., "While this variant of the MUC5B ...
(Date:5/22/2013)... John Mathews from the University of Melbourne said this ... the undoubted benefits from CT scans in diagnosing and ... the British Medical Journal today and involved ... and the International Agency for Research on Cancer in ... were very useful in providing detailed three dimensional pictures ...
(Date:5/22/2013)... 21 May 2013, Paris, France: Results from ... 2013 today question whether bivalirudin is superior ... blockade, showing similar 30-day mortality in patients ... (NSTE-ACS) undergoing percutaneous coronary intervention (PCI)., European ... alone as an alternative to unfractionated heparin ...
Breaking Medicine News(10 mins):Health News:Dental SEO Blog Launched by E-Dentists.com in Partnership with JD Media Surge, LLC 2Health News:Project Managers Organize Manufacturing Projects and Training with the New Steptracker Project Status Magnetic Whiteboards 2Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:Small increase in cancer risk following CT scans in childhood and adolescence 2Health News:Registry questions superiority of bivalirudin over heparin 2
... study has found that Hypnotherapy can be used to relieve ... ,In a small study researchers randomly divided 28 patients ... group received 12 sessions of hypnotherapy over 17 weeks while ... placebo or dummy medicine. , ,According to the BMJ, ...
... Endocrinologists (AACE) Fifteenth Annual Meeting and Clinical Congress to ... 26-30 will discuss important benefits //of vitamin D and ... ,Vitamin D has been in the new ... has been attributed to it. Recent studies have highlighted ...
... According to a large study by Boston University, Black women ... greater risk of breast cancer.// ,The study was published ... Medicine., ,This study is unique because there are previous ... and so it would benefit. ,Lead researcher Dr. Lynn ...
... Madhya Pradesh fell ill after feasting at a marriage dinner, ... police said Thursday. // ,While 65 affected people ... after first aid, a hospital spokesman said. ,Earlier, ... feast. ,While many of those admitted to hospital ...
... have found a link between diet and ALS saying ... progression of Amyotrophic Lateral Sclerosis (ALS). // The Mount ... a correlation between diet and neuronal cell death, the ... an adult-onset neurodegenerative disorder in which spinal and cortical ...
... funded the sex-swap surgery of a former sailor is now ... Bainbridge, 57, from Middleton, says she needs the ?2,500 laser ... wear sleevless dresses in the summer. ,Middleton and ... is waiting for a date for surgery at Charing Cross ...
Cached Medicine News:
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... May 21, 2013  LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, announces that all nominees to ... at today,s annual meeting of stockholders.  These Directors are: ... President of Bahl & Gaynor Investment Counsel , ... , Edgar F. Heizer III , ...
(Date:5/21/2013)... 21, 2013  Decision Resources, one of ... for pharmaceutical and healthcare issues, finds that ... key efficacy endpoints, including overall survival and ... influence over surveyed U.S. and European oncologists, ... HER2-negative breast cancer. The two novel emerging ...
Breaking Medicine Technology:Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3LCA-Vision Reports on Annual Meeting of Stockholders 2LCA-Vision Reports on Annual Meeting of Stockholders 3LCA-Vision Reports on Annual Meeting of Stockholders 4Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer 2
... VILLAGE, Colo. , June 28 Recondo ... the healthcare industry, announced today the general availability of ... and disparate hospital systems, applications, software services, and databases. ... developed decades ago, hospitals have been forced to deploy ...
... 28 Reportlinker.com announces that a new market research report is available in its ... Global Melanoma Therapeutics industry , ... http://www.reportlinker.com/p0197206/Global-Melanoma-Therapeutics-industry.html , ... analyzes the worldwide markets for Melanoma Therapeutics in US$ Million. The report provides separate comprehensive ...
Cached Medicine Technology:Recondo Technology Announces Integration Initiative for US Hospital Systems 2Recondo Technology Announces Integration Initiative for US Hospital Systems 3Recondo Technology Announces Integration Initiative for US Hospital Systems 4Global Melanoma Therapeutics Industry 2Global Melanoma Therapeutics Industry 3Global Melanoma Therapeutics Industry 4Global Melanoma Therapeutics Industry 5Global Melanoma Therapeutics Industry 6Global Melanoma Therapeutics Industry 7Global Melanoma Therapeutics Industry 8Global Melanoma Therapeutics Industry 9Global Melanoma Therapeutics Industry 10Global Melanoma Therapeutics Industry 11Global Melanoma Therapeutics Industry 12
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: